Markel is getting more and more invested in the non-insurance business (like BRK). Adjusted EBITDA for the Markel Ventures segment (the non-insurance business) was $95.1 million in 2014. They note in the letter to shareholders that back as recently as 2004, MKL's underwriting profit (which is pretty much the same as EBITDA) was $72 million. So the non-insurance business is bigger now than the insurance business was ten years ago. Well, there was a big merger (Alterra), but still.
MKL does a great job of describing what they do and how they do it in the letter. I am not going to get into much detail, but I thought I'd make some comments about MKL in general.
First, just a reminder of how MKL makes decisions on capital allocation. It's nice when it's written out like this clearly:
Capital Allocation
I just grabbed the first sentence of each paragraph or section that talks about what MKL does with their capital:
- First, we look to support organic growth in our existing insurance and Markel Ventures operations.
- Second, we can pursue acquisitions in the realm of insurance or non-insurance businesses (that should cover it).
- Thirdly, we acquire publicly traded equity and fixed income securities for the dual purposes of supporting our insurance operations and earning good returns on our capital.
- Our fourth and final choice for capital allocation happens when we believe that the repurchase of our own shares creates better returns than any of the first three choices.
How They Pick Stocks
This is the same thing written every year, but is always good to remember:
As to our equity selection process we continue to use our durable four step process in seeking excellent long-term investments. We look for, one, profitable businesses with good returns on capital and modest leverage; two, management teams with equal measures of talent and integrity; three, businesses with reinvestment opportunities and/or capital discipline, at; four, reasonable valuations. You'll find this language in every Markel annual report since 1999. We believed in this approach since the beginning. We just started explicitly stating it in the annual report that year. Expect this language to continue in future annual reports.
Long Term Performance
I like looking at things over the long term and it's great when there is consistency and comparability over the years with a company. MKL is a great company to follow because they have the letter to shareholders going back to 1986 posted on the website, and their annual reports have financial metrics also going back to 1986.
Here is a table of MKL's BPS growth and equity portfolio performance over the years versus the S&P 500 index (total return). I also put BRK (BPS basis) in the table as a comp. I actually did this for an earlier MKL post and I just updated it.
At the bottom, I put the 5, 10 and 20 year returns. And in the spirit of looking at things "through-the-cycle", I also put the respective returns since the two recent peaks, 1999 and 2007. The MKL equity portfolio return only goes back to 1990 so I don't have a "since 1986" for that. But I think we have enough data here to be impressed with the performance there.
MKL versus the S&P 500 and BRK
| MKL | ||||||||
| S&P 500 | equity | |||||||
| BRK | w/dvd | difference | MKL | vs. S&P | vs. BRK | portfolio | vs S&P 500 | |
| 1987 | 19.5% | 5.1% | 14.4% | 36.3% | 31.2% | 16.8% | ||
| 1988 | 20.1% | 16.6% | 3.5% | 97.9% | 81.3% | 77.8% | ||
| 1989 | 44.4% | 31.7% | 12.7% | 26.8% | -4.9% | -17.6% | ||
| 1990 | 7.4% | -3.1% | 10.5% | -12.1% | -9.0% | -19.5% | -7.0% | -3.9% |
| 1991 | 39.6% | 30.6% | 9.0% | 51.8% | 21.2% | 12.2% | 26.9% | -3.7% |
| 1992 | 20.3% | 7.5% | 12.8% | 29.8% | 22.3% | 9.5% | 13.1% | 5.6% |
| 1993 | 14.3% | 10.1% | 4.2% | 37.5% | 27.4% | 23.2% | 28.7% | 18.6% |
| 1994 | 13.9% | 1.3% | 12.6% | -7.6% | -8.9% | -21.5% | -3.3% | -4.6% |
| 1995 | 43.1% | 37.6% | 5.5% | 53.1% | 15.5% | 10.0% | 29.7% | -7.9% |
| 1996 | 31.8% | 23.0% | 8.8% | 24.9% | 1.9% | -6.9% | 26.9% | 3.9% |
| 1997 | 34.1% | 33.4% | 0.7% | 32.6% | -0.8% | -1.5% | 31.4% | -2.0% |
| 1998 | 48.3% | 28.6% | 19.7% | 18.2% | -10.4% | -30.1% | 13.3% | -15.3% |
| 1999 | 0.5% | 21.0% | -20.5% | -10.9% | -31.9% | -11.4% | -10.3% | -31.3% |
| 2000 | 6.5% | -9.1% | 15.6% | 49.6% | 58.7% | 43.1% | 26.4% | 35.5% |
| 2001 | -6.2% | -11.9% | 5.7% | 7.7% | 19.6% | 13.9% | 16.9% | 28.8% |
| 2002 | 10.0% | -22.1% | 32.1% | 6.7% | 28.8% | -3.3% | -8.8% | 13.3% |
| 2003 | 21.0% | 28.7% | -7.7% | 19.1% | -9.6% | -1.9% | 31.0% | 2.3% |
| 2004 | 10.5% | 10.9% | -0.4% | 19.8% | 8.9% | 9.3% | 15.2% | 4.3% |
| 2005 | 6.4% | 4.9% | 1.5% | 3.5% | -1.4% | -2.9% | -0.3% | -5.2% |
| 2006 | 18.4% | 15.8% | 2.6% | 32.0% | 16.2% | 13.6% | 25.9% | 10.1% |
| 2007 | 11.0% | 5.5% | 5.5% | 15.4% | 9.9% | 4.4% | -0.4% | -5.9% |
| 2008 | -9.6% | -37.0% | 27.4% | -16.2% | 20.8% | -6.6% | -34.0% | 3.0% |
| 2009 | 19.8% | 26.5% | -6.7% | 27.2% | 0.7% | 7.4% | 25.7% | -0.8% |
| 2010 | 13.0% | 15.1% | -2.1% | 15.5% | 0.4% | 2.5% | 20.8% | 5.7% |
| 2011 | 4.6% | 2.1% | 2.5% | 7.9% | 5.8% | 3.3% | 3.8% | 1.7% |
| 2012 | 14.4% | 16.0% | -1.6% | 14.7% | -1.3% | 0.3% | 19.6% | 3.6% |
| 2013 | 18.2% | 32.4% | -14.2% | 18.2% | -14.2% | 0.0% | 33.3% | 0.9% |
| 2014 | 8.3% | 13.7% | -5.4% | 14.0% | 0.3% | 5.7% | 18.6% | 4.9% |
| 5 year | 11.6% | 15.5% | -3.9% | 14.0% | -1.5% | 2.4% | 21.6% | 6.1% |
| 10 year | 10.1% | 7.7% | 2.4% | 12.5% | 4.8% | 2.3% | 12.4% | 4.7% |
| 20 year | 14.3% | 9.9% | 4.5% | 16.5% | 6.6% | 2.2% | 12.7% | 2.9% |
| Since 1986 | 16.4% | 10.4% | 6.0% | 19.8% | 9.4% | 3.4% | 12.3% | |
| Since 1999 | 9.4% | 4.2% | 5.2% | 14.8% | 10.6% | 5.4% | 11.3% | 7.1% |
| Since 2007 | 9.4% | 7.3% | 2.1% | 10.8% | 3.5% | 1.4% | 10.1% | 2.9% |
This is a pretty amazing record. MKL's BPS growth outperforms the S&P 500 index and BRK in every time period except for the five year return (lags the S&P 500 index). BPS has outpaced both the S&P 500 index and BRK by wide margins since both the 1999 and 2007 peaks. The equity portfolio also outperformed the S&P 500 index by pretty wide margins in all time periods. The 700 bps outperformance since the 1999 peak is pretty impressive as is the five year return.
BPS versus Change in BPS
In recent annual reports, MKL has talked about how BPS has been an important metric when MKL was an insurance company, but that this is less and less the case so BPS won't be as important as in the past. They want us to focus on the change in BPS instead of the level itself. This is sort of what Buffett is saying too about BRK's BPS (even though he has a different way of showing intrinsic value).
There are things that change BPS but don't show up in earnings, so they feel the change in BPS over time shows the real earnings power of the company.
So what does that mean for us? If we take that at face value, then we can just look at the change in BPS over time as earnings and then slap an earnings multiple on it to get a valuation. It's definitely true that EPS is not very useful in companies like MKL; it's the comprehensive income that matters. And that is reflected in changes in BPS.
What's MKL Worth?
So then, let's see what MKL is worth if we look at a "normalized" earnings rate and a P/E multiple. MKL's BPS is around $544/share now. Last year was a pretty strong year in the stock market and it was very quiet in the insurance world (not a lot of big events) so earnings might be above trend.
But over time, MKL has grown BPS at double digit rates. The five, ten and twenty year returns were around 14%, 13% and 17%/year. Maybe the 20 year rate of return is skewed higher by the early years. So we can use 13%-14%/year. Let's say 13%.
If, over time, MKL can grow BPS at 13%/year, that implies comprehensive EPS of around $71/share. If MKL traded at the market P/E, say 17x, that would value MKL at $1,200/share. The long term P/E of stocks in general has been around 14x (for the past 100 years or so). Put a 14x multiple on $71/share gives us a fair value of MKL of around $990/share.
MKL is now trading around $780/share.
Here is this idea laid out in a table. The percentage is the growth in BPS (or comprehensive ROE) over time of MKL and the top row is the P/E ratios. So to get the fair value of MKL using the various assumptions, just look for the figure in the table. For example, if MKL has a normalized comprehensive ROE of 13% and trades at a 14x P/E, MKL would trade at $990/share.
Markel Fair Value Given Comprehensive ROE and P/E Ratio
| P/E | |||||||
| %growth | 8 | 10 | 12 | 14 | 16 | 18 | 20 |
| 8% | 348 | 435 | 522 | 609 | 696 | 783 | 870 |
| 9% | 392 | 490 | 588 | 685 | 783 | 881 | 979 |
| 10% | 435 | 544 | 653 | 762 | 870 | 979 | 1,088 |
| 11% | 479 | 598 | 718 | 838 | 957 | 1,077 | 1,197 |
| 12% | 522 | 653 | 783 | 914 | 1,044 | 1,175 | 1,306 |
| 13% | 566 | 707 | 849 | 990 | 1,132 | 1,273 | 1,414 |
| 14% | 609 | 762 | 914 | 1,066 | 1,219 | 1,371 | 1,523 |
| 15% | 653 | 816 | 979 | 1,142 | 1,306 | 1,469 | 1,632 |
| 16% | 696 | 870 | 1,044 | 1,219 | 1,393 | 1,567 | 1,741 |
| 17% | 740 | 925 | 1,110 | 1,295 | 1,480 | 1,665 | 1,850 |
| 18% | 783 | 979 | 1,175 | 1,371 | 1,567 | 1,763 | 1,958 |
| 19% | 827 | 1,034 | 1,240 | 1,447 | 1,654 | 1,860 | 2,067 |
| 20% | 870 | 1,088 | 1,306 | 1,523 | 1,741 | 1,958 | 2,176 |
Of course, this table can be converted so that the output is not a fair value for MKL, but a fair value P/B multiple. This way, we can use the table to value other companies (like BRK, Y etc.):
Fair Value P/B Ratio Given Comprehensive ROE and P/E Multiple
| P/E | |||||||
| %growth | 8 | 10 | 12 | 14 | 16 | 18 | 20 |
| 8% | 0.64 | 0.80 | 0.96 | 1.12 | 1.28 | 1.44 | 1.60 |
| 9% | 0.72 | 0.90 | 1.08 | 1.26 | 1.44 | 1.62 | 1.80 |
| 10% | 0.80 | 1.00 | 1.20 | 1.40 | 1.60 | 1.80 | 2.00 |
| 11% | 0.88 | 1.10 | 1.32 | 1.54 | 1.76 | 1.98 | 2.20 |
| 12% | 0.96 | 1.20 | 1.44 | 1.68 | 1.92 | 2.16 | 2.40 |
| 13% | 1.04 | 1.30 | 1.56 | 1.82 | 2.08 | 2.34 | 2.60 |
| 14% | 1.12 | 1.40 | 1.68 | 1.96 | 2.24 | 2.52 | 2.80 |
| 15% | 1.20 | 1.50 | 1.80 | 2.10 | 2.40 | 2.70 | 3.00 |
| 16% | 1.28 | 1.60 | 1.92 | 2.24 | 2.56 | 2.88 | 3.20 |
| 17% | 1.36 | 1.70 | 2.04 | 2.38 | 2.72 | 3.06 | 3.40 |
| 18% | 1.44 | 1.80 | 2.16 | 2.52 | 2.88 | 3.24 | 3.60 |
| 19% | 1.52 | 1.90 | 2.28 | 2.66 | 3.04 | 3.42 | 3.80 |
| 20% | 1.60 | 2.00 | 2.40 | 2.80 | 3.20 | 3.60 | 4.00 |
So from this table, we see that if we think MKL's normalized earnings level is 13% and trades at a 14x P/E multiple, it should trade at 1.8x BPS.
Of course, this is just one way to look at this. There is a problem with this sort of analysis if there is too much financial assets on the balance sheet.
For example, if MKL sold everything and then just owned an S&P 500 index fund, then one can argue that the long term return of the stock market is 10% and so the normalized comprehensive ROE of MKL is 10%. Slap a 14x multiple on that and suddenly, the S&P 500 index fund is worth 1.4x BPS. (Financial alchemy!). Well, there are taxes. And obviously, noone would put a 14x multiple on this entity.
So again, it's just one way to look at things. We have to be careful not to create alchemic value (that won't be realized).
But otherwise, MKL is an above average company and has a very good long term track record outperforming the market (on an earnings or value creative basis), so at least a market multiple is not unreasonable. If today's market P/E is too high, then we can at least use the long run market average.
Float Better than Equity
And here's another thought. Someone posted a comment in my BRK post that float is better than equity. I don't want to get into that discussion here too much, but it's an old argument. Basically, since BRK makes money on the float (negative cost of float), it's better than equity. And float also grows (or at least has grown until recently; going forward, I don't know if we can bake growth into any valuation cake as Buffett seems to be talking down any expectation of float growth and is insisting on at worst, a very slow decine in float).
So if that's the case, float shouldn't be deducted against assets in any valuation. The two column approach to BRK valuation basically assumes that float is as good as equity since full value is given to investments held per share.
Where am I going with this? Well, MKL too has a really good long term underwriting record. So is float as good as equity for them too?
Check out this long term data (from the annual report). The gray area to the right is stuff I calculated myself for reference. The other data is directly out of the annual report:
MKL Long Term Performance
| Gross | Port | 5-year | Written | |||||||||
| written | Comb | Inv | per | SH | CAGR in | Closing | prems/ | Inv | Price / | |||
| prems | ratio | port | share | equity | BPS | BPS | price | P/B | equity | lev | inv/share | |
| 1989 | 44 | 78% | 79 | $14.54 | 60 | $11.69 | na | 0.00 | 0.73 | 1.32 | 0.00 | |
| 1990 | 412 | 81% | 411 | $77.27 | 55 | $10.27 | na | $11.75 | 1.14 | 7.49 | 7.47 | 0.15 |
| 1991 | 406 | 106% | 436 | $81.77 | 83 | $15.59 | 35% | $22.00 | 1.41 | 4.89 | 5.25 | 0.27 |
| 1992 | 304 | 97% | 457 | $84.64 | 109 | $20.24 | 34% | $31.25 | 1.54 | 2.79 | 4.19 | 0.37 |
| 1993 | 313 | 97% | 609 | $112.55 | 151 | $27.83 | 25% | $39.38 | 1.42 | 2.07 | 4.03 | 0.35 |
| 1994 | 349 | 97% | 622 | $115.45 | 139 | $25.71 | 17% | $41.50 | 1.61 | 2.51 | 4.47 | 0.36 |
| 1995 | 402 | 99% | 927 | $170.95 | 213 | $39.37 | 31% | $75.50 | 1.92 | 1.89 | 4.35 | 0.44 |
| 1996 | 414 | 100% | 1142 | $209.20 | 268 | $49.16 | 26% | $85.00 | 1.73 | 1.54 | 4.26 | 0.41 |
| 1997 | 423 | 99% | 1410 | $257.51 | 357 | $65.18 | 26% | $156.13 | 2.40 | 1.18 | 3.95 | 0.61 |
| 1998 | 437 | 98% | 1483 | $268.49 | 425 | $77.02 | 23% | $181.00 | 2.35 | 1.03 | 3.49 | 0.67 |
| 1999 | 595 | 101% | 1625 | $290.69 | 383 | $68.59 | 22% | $155.00 | 2.26 | 1.55 | 4.24 | 0.53 |
| 2000 | 1,132 | 114% | 3136 | $427.79 | 752 | $102.63 | 21% | $181.00 | 1.76 | 1.51 | 4.17 | 0.42 |
| 2001 | 1,774 | 124% | 3591 | $365.70 | 1,085 | $110.50 | 18% | $179.65 | 1.63 | 1.64 | 3.31 | 0.49 |
| 2002 | 2,218 | 103% | 4314 | $438.79 | 1,159 | $117.89 | 13% | $205.50 | 1.74 | 1.91 | 3.72 | 0.47 |
| 2003 | 2,572 | 99% | 5350 | $543.31 | 1,382 | $140.38 | 13% | $253.51 | 1.81 | 1.86 | 3.87 | 0.47 |
| 2004 | 2,518 | 96% | 6317 | $641.49 | 1,657 | $168.22 | 20% | $364.00 | 2.16 | 1.52 | 3.81 | 0.57 |
| 2005 | 2,401 | 101% | 6588 | $672.34 | 1,705 | $174.04 | 11% | $317.05 | 1.82 | 1.41 | 3.86 | 0.47 |
| 2006 | 2,536 | 87% | 7524 | $752.80 | 2,296 | $229.78 | 16% | $480.10 | 2.09 | 1.10 | 3.28 | 0.64 |
| 2007 | 2,359 | 88% | 7775 | $780.84 | 2,641 | $265.26 | 18% | $491.10 | 1.85 | 0.89 | 2.94 | 0.63 |
| 2008 | 2,213 | 99% | 6893 | $702.34 | 2,181 | $222.20 | 10% | $299.00 | 1.35 | 1.01 | 3.16 | 0.43 |
| 2009 | 1,906 | 95% | 7849 | $799.34 | 2,774 | $282.55 | 11% | $340.00 | 1.20 | 0.69 | 2.83 | 0.43 |
| 2010 | 1,982 | 97% | 8224 | $846.24 | 3,172 | $326.36 | 13% | $378.13 | 1.16 | 0.62 | 2.59 | 0.45 |
| 2011 | 2,291 | 102% | 8728 | $907.20 | 3,388 | $352.10 | 9% | $414.67 | 1.18 | 0.68 | 2.58 | 0.46 |
| 2012 | 2,514 | 97% | 9333 | $969.23 | 3,889 | $403.85 | 9% | $433.42 | 1.07 | 0.65 | 2.40 | 0.45 |
| 2013 | 3,920 | 97% | 17612 | $1,259.26 | 6,674 | $477.16 | 17% | $580.35 | 1.22 | 0.59 | 2.64 | 0.46 |
| 2014 | 4,806 | 95% | 18638 | $1,334.89 | 7,595 | $543.96 | 14% | $682.84 | 1.26 | 0.63 | 2.45 | 0.51 |
Inv port = Investment portfolio
SH equity = Shareholders' equity
Inv lev = Investment leverage (total investments / shareholders' equity)
Price / inv/share = Stock price divided by investments per share
Combined Ratio
The combined ratio at MKL for various time periods (average) are:
Since 1989: 98.0
5 year: 97.6
10 year: 95.8
20 year: 99.6
The combined ratio has been under 100 in all time periods. If BRK's float is as good as equity, I would argue that this is also true at MKL.
Investments per share at MKL at the end of 2014 was $1,335. So, borrowing from BRK's two column valuation idea, we can say that MKL is actually worth, right now, $1,335/share. This assumes break even underwriting and no value to Markel Ventures, which has almost $100 million in adjusted EBITDA.
If MKL was valued at investments per share, how would you have done over the years?
Increase in Investments per Share
1 year +6.0%
5 year +10.8%
10 year +7.6%
20 year +13.0%
Since 1989 +20.0%
This reflects total investment return and change in float.
Going forward, we would have to add the value created by Markel Ventures, which is not reflected at all in this "left column" valuation of MKL. We will have to add the right column over time as it gets bigger.
As reasonable as all of this sounds, you will notice (far right column in above table) that MKL has never traded at anything close to investments per share.
Conclusion
Anyway, MKL is a great company and is doing really well. I don't know the correct way to value MKL, but I just looked at some interesting approaches to see what valuations I can come up with given what MKL has said in their annual report(s), on what Buffett has said about BRK etc.
I'm sort of just putting these different things together in a logical way to see what comes out.
It seems reasonable to me that MKL can trade at $1,000/share. It doesn't seem like too much of a stretch to me. But will it ever get there? I have no idea. I just think it would be OK if it did.
Check out the report, it's definitely worth the time!